{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:39Z","timestamp":1787027019822,"version":"build-2736575974"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01305","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:31:06Z","timestamp":1598610666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis\/Bladder Pain Syndrome in Rats"],"prefix":"10.3389","volume":"11","author":[{"given":"C\u00e9line","family":"Aug\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Vergnolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lluel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1242\/dmm.027706","article-title":"A RATional choice for translational research","volume":"9","author":"Aitman","year":"2016","journal-title":"Dis. Model Mech."},{"key":"B3","doi-asserted-by":"publisher","first-page":"F111","DOI":"10.1152\/ajprenal.00139.2013","article-title":"Expression and function of CCL2\/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation","volume":"305","author":"Arms","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2013.03.008","article-title":"Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder","volume":"707","author":"Aug\u00e9","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5213\/inj.1835062.531","article-title":"Animal Modelling of Interstitial Cystitis\/Bladder Pain Syndrome","volume":"22","author":"Birder","year":"2018","journal-title":"Int. Neurourol. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/01.ju.0000079766.49550.94","article-title":"Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences","volume":"170","author":"Bon","year":"2003","journal-title":"J. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0022-5347(05)67495-2","article-title":"Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain","volume":"164","author":"Boucher","year":"2000","journal-title":"J. Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/nau.21180","article-title":"Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice","volume":"30","author":"Boudes","year":"2011","journal-title":"Neurourol. Urodyn"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/nau.23091","article-title":"A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome\/interstitial cystitis","volume":"36","author":"Cervigni","year":"2017","journal-title":"Neurourol. Urodyn"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1023\/a:1011981317451","article-title":"Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats","volume":"15","author":"Chiou","year":"1998","journal-title":"Pharm. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1113\/jphysiol.2004.071159","article-title":"Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium","volume":"562","author":"Chopra","year":"2005","journal-title":"J. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"E721","DOI":"10.5489\/cuaj.1989","article-title":"Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey","volume":"8","author":"Cicione","year":"2014","journal-title":"Can. Urol. Assoc. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/0006-2952(79)90222-3","article-title":"Cyclophosphamide cystitis\u2013identification of acrolein as the causative agent","volume":"28","author":"Cox","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/art.34345","article-title":"Role of transient receptor potential vanilloid 4 in rat joint inflammation","volume":"64","author":"Denadai-Souza","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0022-5347(05)65517-6","article-title":"How do patients with interstitial cystitis present","volume":"166","author":"Driscoll","year":"2001","journal-title":"J. Urol."},{"key":"B16","article-title":"EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen","volume-title":"EAU Annual Congress","author":"Engeler","year":"2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.eururo.2009.08.020","article-title":"EAU guidelines on chronic pelvic pain","volume":"57","author":"Fall","year":"2010","journal-title":"Eur. Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/nau.20178","article-title":"Visceral and cutaneous sensory testing in patients with painful bladder syndrome","volume":"24","author":"Fitzgerald","year":"2005","journal-title":"Neurourol. Urodyn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/gco.0000000000000083","article-title":"Pain thresholds in women with chronic pelvic pain","volume":"26","author":"Giamberardino","year":"2014","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00260","DOI":"10.1002\/phy2.260","article-title":"The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors","volume":"2","author":"Golubeva","year":"2014","journal-title":"Physiol. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0022-5347(17)44929-9","article-title":"Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy","volume":"136","author":"Gray","year":"1986","journal-title":"J. Urol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1756287218761574","article-title":"Current best practice management of interstitial cystitis\/bladder pain syndrome","volume":"10","author":"Han","year":"2018","journal-title":"Ther. Adv. Urol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment","volume":"193","author":"Hanno","year":"2015","journal-title":"J. Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0090-4295(97)00179-9","article-title":"Analysis of long-term Elmiron therapy for interstitial cystitis","volume":"49","author":"Hanno","year":"1997","journal-title":"Urology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/s0022-5347(17)39611-8","article-title":"Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis","volume":"144","author":"Harrington","year":"1990","journal-title":"J. Urol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.urology.2011.12.053","article-title":"Suicidal ideation among patients with bladder pain syndrome\/interstitial cystitis","volume":"80","author":"Hepner","year":"2012","journal-title":"Urology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"R574","DOI":"10.1152\/ajpregu.00465.2002","article-title":"COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat","volume":"284","author":"Hu","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1242\/dmm.002733","article-title":"Rats","volume":"2","author":"Iannaccone","year":"2009","journal-title":"Dis. Model Mech."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/s0022-5347(17)40201-1","article-title":"Clinical features and spectrum of light microscopic changes in interstitial cystitis","volume":"143","author":"Johansson","year":"1990","journal-title":"J. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1569-9056(09)74821-3","article-title":"Animal models of overactive bladder: cyclophosphamide (CYP)-induced cystitis in rats","volume":"48","author":"Juszczak","year":"2007","journal-title":"Folia Med. Cracov."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008x(92)90089-b","article-title":"Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57\/B16 and ICR mice","volume":"114","author":"Kanekal","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.juro.2010.04.083","article-title":"Gating of sensory information differs in patients with interstitial cystitis\/painful bladder syndrome","volume":"184","author":"Kilpatrick","year":"2010","journal-title":"J. Urol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00005392-199601000-00030","article-title":"Discrimination between the ulcerous and the nonulcerous forms of interstitial cystitis by noninvasive findings","volume":"155","author":"Koziol","year":"1996","journal-title":"J. Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5213\/inj.2013.17.2.78","article-title":"Effect of low-dose triple therapy using gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug for overactive bladder symptoms in patients with bladder pain syndrome","volume":"17","author":"Kwon","year":"2013","journal-title":"Int. Neurourol. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.juro.2013.11.099","article-title":"Segmental hyperalgesia to mechanical stimulus in interstitial cystitis\/bladder pain syndrome: evidence of central sensitization","volume":"191","author":"Lai","year":"2014","journal-title":"J. Urol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1756287215621234","article-title":"Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence","volume":"8","author":"Lazzeri","year":"2016","journal-title":"Ther. Adv. Urol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5213\/inj.2010.14.4.256","article-title":"Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug","volume":"14","author":"Lee","year":"2010","journal-title":"Int. Neurourol. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/15376510903530845","article-title":"Mutagenicity of acrolein and acrolein-induced DNA adducts","volume":"20","author":"Liu","year":"2010","journal-title":"Toxicol. Mech. Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/iju.12370","article-title":"Inflammation characteristics in bladder pain syndrome ESSIC type 3C\/classic interstitial cystitis","volume":"21","author":"Logadottir","year":"2014","journal-title":"Int. J. Urol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/nau.22575","article-title":"How are we going to make progress treating bladder pain syndrome? ICI-RS 2013","volume":"33","author":"Malykhina","year":"2014","journal-title":"Neurourol. Urodyn"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/luts.12214","article-title":"Advances in intravesical therapy for bladder pain syndrome (BPS)\/interstitial cystitis (IC)","volume":"10","author":"Meng","year":"2018","journal-title":"Low. Urin. Tract. Symptoms"},{"key":"B42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cbi.2013.03.008","article-title":"Antagonism of the transient receptor potential ankyrin 1 (TRPA1) attenuates hyperalgesia and urinary bladder overactivity in cyclophosphamide-induced haemorrhagic cystitis","volume":"203","author":"Meotti","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"B43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0090-4295(78)90286-8","article-title":"Interstitial cystitis: early diagnosis, pathology, and treatment","volume":"12","author":"Messing","year":"1978","journal-title":"Urology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/cjn.02000309","article-title":"Interstitial cystitis: an unsolved enigma","volume":"4","author":"Moutzouris","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.ju.0000158452.15915.e2","article-title":"Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis","volume":"173","author":"Ness","year":"2005","journal-title":"J. Urol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.juro.2013.08.024","article-title":"An endogenous pain control system is altered in subjects with interstitial cystitis","volume":"191","author":"Ness","year":"2014","journal-title":"J. Urol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/nau.1930090302","article-title":"Interstitial cystitis: Clinical manifestations and diagnostic criteria in over 200 cases","volume":"9","author":"Parsons","year":"1990","journal-title":"Neurourol. Urodynamics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.urology.2006.03.084","article-title":"The role of the urinary epithelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis","volume":"69","author":"Parsons","year":"2007","journal-title":"Urology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/00005392-200102000-00090","article-title":"Cyclophosphamide-induced hemorrhagic cystitis in rats that underwent colocystoplasty: experimental study","volume":"165","author":"Rod\u00f3","year":"2001","journal-title":"J. Urol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.juro.2011.10.048","article-title":"Gender specific pelvic pain severity in neurogenic cystitis","volume":"187","author":"Rudick","year":"2012","journal-title":"J. Urol."},{"key":"B51","first-page":"47","article-title":"Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain","volume":"7","author":"Sasaki","year":"2001","journal-title":"Tech. Urol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0090-4295(78)90118-8","article-title":"Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders","volume":"11","author":"Shirley","year":"1978","journal-title":"Urology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0165-1161(92)90031-g","article-title":"Species differences in the genotoxicity of cyclophosphamide and styrene in three in vivo assays","volume":"271","author":"Simula","year":"1992","journal-title":"Mutat. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.urology.2008.07.031","article-title":"Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis","volume":"73","author":"Smaldone","year":"2009","journal-title":"Urology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/ncpuro0874","article-title":"Interstitial cystitis and systemic autoimmune diseases","volume":"4","author":"van de Merwe","year":"2007","journal-title":"Nat. Clin. Pract. Urol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003898","article-title":"Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association","volume":"3","author":"Vera","year":"2008","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3181\/0709-rm-240","article-title":"Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation","volume":"233","author":"Vera","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(sici)1096-9861(19960624)370:2<191::aid-cne5>3.0.co;2-y","article-title":"Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation","volume":"370","author":"Vizzard","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0304-3959(97)00076-6","article-title":"The urogenital and rectal pain syndromes","volume":"73","author":"Wesselmann","year":"1997","journal-title":"Pain"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:31:09Z","timestamp":1598610669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":60,"alternative-id":["10.3389\/fphar.2020.01305"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01305","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"article-number":"1305"}}